Tenet Healthcare Corporation (THC) has exhibited a robust long-term uptrend, with shares gaining over 46% in the past year and more than 227% over five years. However, the chart shows a corrective pullback in recent months, with the stock declining nearly 7% year-to-date and 5% over the last 30 days. This short-term downtrend is confirmed by the price trading below the rising trendline and key moving averages, entering a phase of consolidation after peaking near 247 earlier in the 52-week range. The structure suggests a potential exhaustion near quarterly support zones previously tested multiple times, including lows around July and August prior ranges.
Traders are closely monitoring a support cluster between 181.74 and 182.72, aligned with classic pivot S3 and S1 levels, as well as recent lows near 180.49 and 177.84. A break below 181 could accelerate downside toward 177, while holding this zone may stabilize price action. Resistance begins at 183.71 (pivot R1), followed by 184.16 (R2), with stronger barriers at the 50-day MA around 189 and the 100/200-day MAs near 193-195. These levels coincide with prior consolidation ranges and Fibonacci retracements from recent highs.
The moving averages present a neutral summary with six buy and six sell signals across simple and exponential periods from MA5 to MA200. Shorter-term MAs (5-day at 184, 10-day at 183, 20-day at 184) show buy signals as price hovers near these levels, but longer-term MAs (50-day 189 sell, 100-day 193 sell, 200-day 195 sell) indicate bearish pressure. Price action below the 50-day MA at 211 in broader views underscores the downtrend, with the stock 20% off 50-day highs. This configuration points to potential mean reversion if shorter MAs provide support.
Momentum indicators offer mixed readings. RSI(14) at 51 is neutral, neither overbought nor oversold, suggesting room for movement in either direction. Stochastic (9,6) at 77 signals buy, with Williams %R at -5 indicating overbought short-term conditions. MACD(12,26) at -1.36 generates a sell signal, supported by ADX(14) at 24 showing mild selling pressure and CCI(14) at 90 leaning buy. Overall, indicators tilt to buy (5 buys, 3 sells), contrasting moving average neutrality and hinting at possible short-term bounce amid the downtrend.
Volume has spiked on recent downside moves, with daily averages around 1.1-1.7 million shares rising to 2.4 million on pullback days, indicating strong selling interest. The 14-day ATR at 3.5-8.5 reflects elevated volatility at 38-39%, consistent with sharp 4% daily swings. Price has formed lower highs and lows over the last quarter, breaking below prior channel support, but stabilizing near multi-touch lows suggests demand zones forming.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to analyze vast arrays of market data, technical indicators, and historical price patterns for stocks and ETFs like THC. These signals identify potential buy or sell opportunities based on trend recognition, momentum shifts, and recurring chart behaviors observed in similar market conditions. Traders rely on them to pinpoint entry and exit points, validate ongoing trends, and enhance decision-making processes without emotional bias. By processing real-time and historical inputs, the AI provides objective insights that complement manual analysis. Explore these signals to integrate advanced pattern detection into your trading strategy.
Traders will watch for a hold above 182 support to signal potential stabilization and a retest of 184-189 resistance, where shorter-term MAs cluster. A breakdown below 181 could target deeper supports near 178, confirming extended correction. Momentum divergence in RSI or Stochastic, alongside MACD crossover, may hint at reversal. Volume confirmation on any breakout remains crucial amid ongoing volatility, with focus on 50-day MA at 189 as a pivotal battleground for trend resumption.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To THC | 1D Price Change % |
|---|---|---|
| THC | 100% | +0.86% |
| Hospital/Nursing Management industry (51 stocks) | 37% Loosely correlated | +0.06% |